GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (OTCPK:AIHLF) » Definitions » Current Ratio

Adcock Ingram Holdings (Adcock Ingram Holdings) Current Ratio : 1.92 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Adcock Ingram Holdings Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Adcock Ingram Holdings's current ratio for the quarter that ended in Dec. 2023 was 1.92.

Adcock Ingram Holdings has a current ratio of 1.92. It generally indicates good short-term financial strength.

The historical rank and industry rank for Adcock Ingram Holdings's Current Ratio or its related term are showing as below:

AIHLF' s Current Ratio Range Over the Past 10 Years
Min: 1.63   Med: 1.9   Max: 2.12
Current: 1.92

During the past 13 years, Adcock Ingram Holdings's highest Current Ratio was 2.12. The lowest was 1.63. And the median was 1.90.

AIHLF's Current Ratio is ranked better than
51.25% of 1077 companies
in the Drug Manufacturers industry
Industry Median: 1.89 vs AIHLF: 1.92

Adcock Ingram Holdings Current Ratio Historical Data

The historical data trend for Adcock Ingram Holdings's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings Current Ratio Chart

Adcock Ingram Holdings Annual Data
Trend Sep13 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.94 1.76 1.90 1.99 1.90

Adcock Ingram Holdings Semi-Annual Data
Mar14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.89 1.99 2.12 1.90 1.92

Competitive Comparison of Adcock Ingram Holdings's Current Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Adcock Ingram Holdings's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adcock Ingram Holdings's Current Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Adcock Ingram Holdings's Current Ratio distribution charts can be found below:

* The bar in red indicates where Adcock Ingram Holdings's Current Ratio falls into.



Adcock Ingram Holdings Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Adcock Ingram Holdings's Current Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Current Ratio (A: Jun. 2023 )=Total Current Assets (A: Jun. 2023 )/Total Current Liabilities (A: Jun. 2023 )
=246.171/129.86
=1.90

Adcock Ingram Holdings's Current Ratio for the quarter that ended in Dec. 2023 is calculated as

Current Ratio (Q: Dec. 2023 )=Total Current Assets (Q: Dec. 2023 )/Total Current Liabilities (Q: Dec. 2023 )
=251.756/131.208
=1.92

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adcock Ingram Holdings  (OTCPK:AIHLF) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Adcock Ingram Holdings Current Ratio Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Adcock Ingram Holdings (Adcock Ingram Holdings) Business Description

Traded in Other Exchanges
Address
1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.

Adcock Ingram Holdings (Adcock Ingram Holdings) Headlines

From GuruFocus